Virus-induced Immunopathology

Overview

Journal Adv Virus Res

Specialty Microbiology

Date 1996 Jan 1

PMID 8895836

Citations 10

Authors

B T Rouse

Affiliations

Soon will be listed here.

Citing Articles

Controlling viral inflammatory lesions by rebalancing immune response patterns.

Mulik S, Berber E, Sehrawat S, Rouse B Front Immunol. 2023; 14:1257192.

PMID: 37671156 PMC: 10475736. DOI: 10.3389/fimmu.2023.1257192.

Antibody and complement levels in patients with hypersplenism associated with cirrhotic portal hypertension and therapeutic principles.

Zhang K, Zeng M, Li Y, Wu H, Wu J, Zhang Z World J Clin Cases. 2023; 10(36):13208-13215.

PMID: 36683645 PMC: 9850989. DOI: 10.12998/wjcc.v10.i36.13208.

Common Inflammatory Mechanisms in COVID-19 and Parkinson's Diseases: The Role of Microbiome, Pharmabiotics and Postbiotics in Their Prevention.

Danilenko V, Devyatkin A, Marsova M, Shibilova M, Ilyasov R, Shmyrev V J Inflamm Res. 2021; 14:6349-6381.

PMID: 34876830 PMC: 8643201. DOI: 10.2147/JIR.S333887.

The CD8 T Cell Noncytotoxic Antiviral Responses.

Morvan M, Teque F, Locher C, Levy J Microbiol Mol Biol Rev. 2021; 85(2).

PMID: 33980586 PMC: 8139528. DOI: 10.1128/MMBR.00155-20.

Quantification of feline herpesvirus 1 DNA in ocular fluid samples of clinically diseased cats by real-time TaqMan PCR.

Vogtlin A, Fraefel C, Albini S, Leutenegger C, Schraner E, Spiess B J Clin Microbiol. 2002; 40(2):519-23.

PMID: 11825966 PMC: 153372. DOI: 10.1128/JCM.40.2.519-523.2002.

References

Alwan W, Record F, Openshaw P . Phenotypic and functional characterization of T cell lines specific for individual respiratory syncytial virus proteins. J Immunol. 1993; 150(12):5211-8. View

Powrie F, Coffman R . Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol Today. 1993; 14(6):270-4. DOI: 10.1016/0167-5699(93)90044-L. View

Manetti R, Parronchi P, Giudizi M, Piccinni M, Maggi E, Trinchieri G . Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med. 1993; 177(4):1199-204. PMC: 2190961. DOI: 10.1084/jem.177.4.1199. View

TRAUTWEIN G . Immune mechanisms in the pathogenesis of viral diseases: a review. Vet Microbiol. 1992; 33(1-4):19-34. PMC: 7117483. DOI: 10.1016/0378-1135(92)90032-o. View

Kagi D, Ledermann B, Burki K, Zinkernagel R, Hengartner H . Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunol Rev. 1995; 146:95-115. DOI: 10.1111/j.1600-065x.1995.tb00686.x. View

Laskin D, Pendino K . Macrophages and inflammatory mediators in tissue injury. Annu Rev Pharmacol Toxicol. 1995; 35:655-77. DOI: 10.1146/annurev.pa.35.040195.003255. View

Lehmann P, Sercarz E, Forsthuber T, Dayan C, GAMMON G . Determinant spreading and the dynamics of the autoimmune T-cell repertoire. Immunol Today. 1993; 14(5):203-8. DOI: 10.1016/0167-5699(93)90163-F. View

Fleming J, Wang F, Trousdale M, Hinton D, Stohlman S . Interaction of immune and central nervous systems: contribution of anti-viral Thy-1+ cells to demyelination induced by coronavirus JHM. Reg Immunol. 1993; 5(1):37-43. View

Fazakerley J, Buchmeier M . Pathogenesis of virus-induced demyelination. Adv Virus Res. 1993; 42:249-324. PMC: 7131186. DOI: 10.1016/s0065-3527(08)60087-1. View

10.

Ando K, Guidotti L, Cerny A, Ishikawa T, Chisari F . CTL access to tissue antigen is restricted in vivo. J Immunol. 1994; 153(2):482-8. View

11.

Zaki S, Greer P, Coffield L, Goldsmith C, Nolte K, Foucar K . Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. Am J Pathol. 1995; 146(3):552-79. PMC: 1869168. View

12.

Shearer G . Pharmacology. Redirecting T-cell function. Nature. 1995; 377(6544):16-7. DOI: 10.1038/377016a0. View

13.

Doherty P, Hou S, Southern P . Lymphocytic choriomeningitis virus induces a chronic wasting disease in mice lacking class I major histocompatibility complex glycoproteins. J Neuroimmunol. 1993; 46(1-2):11-7. DOI: 10.1016/0165-5728(93)90228-q. View

14.

Campbell I, Samimi A, Chiang C . Expression of the inducible nitric oxide synthase. Correlation with neuropathology and clinical features in mice with lymphocytic choriomeningitis. J Immunol. 1994; 153(8):3622-9. View

15.

Tumpey T, Elner V, Chen S, Oakes J, Lausch R . Interleukin-10 treatment can suppress stromal keratitis induced by herpes simplex virus type 1. J Immunol. 1994; 153(5):2258-65. View

16.

Buchmeier M, Welsh R, Dutko F, Oldstone M . The virology and immunobiology of lymphocytic choriomeningitis virus infection. Adv Immunol. 1980; 30:275-331. DOI: 10.1016/s0065-2776(08)60197-2. View

17.

Babu J, Thomas J, Kanangat S, Morrison L, Knipe D, Rouse B . Viral replication is required for induction of ocular immunopathology by herpes simplex virus. J Virol. 1996; 70(1):101-7. PMC: 189793. DOI: 10.1128/JVI.70.1.101-107.1996. View

18.

Bluestone J . New perspectives of CD28-B7-mediated T cell costimulation. Immunity. 1995; 2(6):555-9. DOI: 10.1016/1074-7613(95)90000-4. View

19.

Croft M, Carter L, Swain S, Dutton R . Generation of polarized antigen-specific CD8 effector populations: reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles. J Exp Med. 1994; 180(5):1715-28. PMC: 2191720. DOI: 10.1084/jem.180.5.1715. View

20.

Avery A, Zhao Z, Rodriguez A, Bikoff E, Soheilian M, Foster C . Resistance to herpes stromal keratitis conferred by an IgG2a-derived peptide. Nature. 1995; 376(6539):431-4. DOI: 10.1038/376431a0. View